Immediate Impact
64 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of Ganesh Jevalikar being referenced
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ganesh Jevalikar | 411 | 63 | 161 | 347 | 27 | 665 | |
| Deniz Duman | 195 | 21 | 176 | 330 | 34 | 585 | |
| Atakan Yeşıl | 185 | 81 | 122 | 417 | 27 | 766 | |
| Guido Baselli | 275 | 52 | 116 | 575 | 28 | 831 | |
| Sang Bae Lee | 370 | 35 | 121 | 278 | 16 | 769 | |
| Sonia L. La’ulu | 295 | 33 | 65 | 126 | 44 | 768 | |
| Sung Woo Park | 367 | 65 | 131 | 294 | 33 | 766 | |
| Kamaljit Chatha | 155 | 20 | 94 | 262 | 21 | 778 | |
| Damien Denimal | 381 | 34 | 159 | 448 | 41 | 801 | |
| Elizabeth Rosolowsky | 261 | 140 | 150 | 118 | 21 | 788 | |
| Maria Masulli | 321 | 86 | 92 | 188 | 41 | 752 |
All Works
Login with ORCID to disown or claim papers
Loading papers...